CN112920280A - Method for efficiently expressing acid protease and application thereof - Google Patents

Method for efficiently expressing acid protease and application thereof Download PDF

Info

Publication number
CN112920280A
CN112920280A CN202110436308.0A CN202110436308A CN112920280A CN 112920280 A CN112920280 A CN 112920280A CN 202110436308 A CN202110436308 A CN 202110436308A CN 112920280 A CN112920280 A CN 112920280A
Authority
CN
China
Prior art keywords
acid protease
alpha
recombinant
signal peptide
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110436308.0A
Other languages
Chinese (zh)
Other versions
CN112920280B (en
Inventor
吴丹
郑璞
陈鹏程
魏梦园
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangnan University
Original Assignee
Jiangnan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangnan University filed Critical Jiangnan University
Priority to CN202110436308.0A priority Critical patent/CN112920280B/en
Publication of CN112920280A publication Critical patent/CN112920280A/en
Application granted granted Critical
Publication of CN112920280B publication Critical patent/CN112920280B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/58Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12GWINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
    • C12G1/00Preparation of wine or sparkling wine
    • C12G1/02Preparation of must from grapes; Must treatment and fermentation
    • C12G1/0203Preparation of must from grapes; Must treatment and fermentation by microbiological or enzymatic treatment
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P60/00Technologies relating to agriculture, livestock or agroalimentary industries
    • Y02P60/80Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
    • Y02P60/87Re-use of by-products of food processing for fodder production

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses a method for efficiently expressing acid protease and application thereof, belonging to the field of genetic engineering. The recombinant pichia pastoris GS115/pPIC 9K-en-alpha SP-acid protein has the expression enzyme activity reaching 5395U/mL, the enzyme activity is improved by 109% compared with the enzyme production enzyme activity of a control strain containing original alpha-signal peptide, the acid protein can maintain more than 60% of the enzyme activity within the pH range of 1-5, the residual enzyme activity after 30min treatment at 20-40 ℃ is more than 80%, and the recombinant pichia pastoris P.pastoris GS115/pPIC 9K-en-alpha SP-acid protein can be applied to the industries of food, feed or brewing and the like. According to the technical scheme of the invention, the acidic protease suitable for industrial application can be produced by utilizing a genetic engineering means.

Description

Method for efficiently expressing acid protease and application thereof
Technical Field
The invention relates to a method for efficiently expressing acid protease and application thereof, belonging to the field of genetic engineering.
Background
Proteases are a class of enzymes that catalyze proteolysis, which is widely found in plants, animals, and microorganisms. Compared with protease derived from animals and plants, the protease derived from microorganisms has the characteristics of convenient culture, simple operation and high enzyme yield, and is convenient for industrial mass production and large-scale production and application. Therefore, proteases of microbial origin are an important source of current proteases.
Proteases are classified in many ways, and are classified into acid proteases, alkaline proteases and neutral proteases according to the pH at which the protease acts. The acidic protease is generally stable at a pH of 2.0-6.0, and the optimum pH value is slightly different depending on the species, but is generally about pH 3.0, for example, the acidic protease produced by fungi has an optimum pH of 3.0, Penicillium griseovirens has a pH of 3.5, and the yeast has a pH of 3.0. The enzyme has high sequence similarity, and the three-dimensional structure of the enzyme is in a symmetrical double-leaf shape. Proteases, depending on the active center, are classified into: serine proteases, aspartic proteases, cysteine proteases, and metallo proteases.
The acidic protease is widely applied to the industries of food, brewing, fur and leather, medicine, feed and the like. During the fermentation process of brewing the white spirit, acidic protease is utilized to play a synergistic role, particles of fermentation raw materials are dissolved, the utilization rate of the raw materials is improved, the growth of microorganisms is promoted, proteins are decomposed to provide aroma precursor substances and flavor substances, and yeast mycoprotein is decomposed. In the manufacturing process of fur and leather, acid protease removes the fiber matrix, so that the leather is softer and plump. In the feed industry, the addition of the acidic protease can improve the digestibility of protein, so that high-molecular protein is degraded into low-molecular peptide and amino acid, the digestion and absorption of livestock and poultry are facilitated, the stimulation of the feed to the digestive tract of young animals can be reduced, the nutritional disorder is reduced, the utilization rate of the feed is improved, and the growth of the livestock and poultry is promoted.
In the prior art, wild acid protease has poor performance and low yield and can not meet the market demand far away, so that the wild acid protease is difficult to be really applied to industrial production. At present, the means of constructing genetically engineered bacteria is often adopted to enhance the transcription and translation of acid protease genes so as to improve the yield of acid protease.
Most of the acid protease currently used for industrial production is mould acid protease, the optimum action pH growth value of the enzyme is about 3.0, when the pH value is increased, the enzyme activity of the acid protease can be obviously reduced, and the enzyme is thermolabile and is unstable when the temperature reaches above 50 ℃. Therefore, the enzyme activity of the acid protease is not high, and the difference between the optimal action condition of the enzyme and the environment condition catalyzed by the enzyme in the aspects of pH, temperature and the like causes the reduction of the catalytic efficiency of the enzyme, thereby limiting the application of the acid protease in industry.
Disclosure of Invention
The technical problem to be solved by the invention is to provide a method for efficiently expressing acid protease.
The first purpose of the invention is to provide a fusion protein, wherein the fusion protein is an acid protease with an enhanced alpha-signal peptide connected to the N end; the nucleotide sequence of the acid protease is shown as SEQ ID NO. 2; the nucleotide sequence of the enhanced alpha-signal peptide is shown in SEQ ID NO. 4.
In one embodiment, the amino acid sequence of the acidic protease is shown as SEQ ID NO. 1; the amino acid sequence of the enhanced alpha-signal peptide is shown in SEQ ID NO. 3.
The second purpose of the invention is to provide a vector for expressing the fusion protein.
It is a third object of the present invention to provide a recombinant strain containing the fusion protein or vector.
In one embodiment, the recombinant strain is host pichia pastoris.
In one embodiment, the recombinant strain is vectored with pPIC 9K.
In one embodiment, the host pichia is GS115, KM71, and X33.
The fourth purpose of the invention is to provide a method for constructing the recombinant strain, which comprises the following specific steps: (1) connecting and inserting the acid protease and the enhanced alpha-signal peptide into an expression vector pUC57 to obtain a recombinant vector pUC57-en alpha-SP-acidiprotea; (2) using a recombinant vector pUC57-en alpha-SP-acidiprotea as a template, carrying out PCR amplification on a target fragment containing acid protease and enhanced alpha-signal peptide, and inserting the target fragment between BamHI HI and Not I of a restriction enzyme site of an expression vector pPIC9K to obtain a recombinant vector pPIC 9K-en-alpha SP-acidiprotea; (3) the plasmid was linearized with Sac I and electrotransferred to Pichia pastoris to obtain the recombinant strain P.pastoris GS115/pPIC9K-en- α SP-acidprotea.
The fifth purpose of the invention is to provide a method for improving the expression level of acid protease, which comprises the following steps: connecting the gene sequence of the enhanced alpha-signal peptide to the N end of the acid protease gene sequence; the nucleotide sequence of the enhanced alpha-signal peptide is shown as SEQ ID NO. 4; the acid protease comprises acid protease of animal or fungus origin.
In one embodiment, the acid protease has the sequence shown in SEQ ID NO. 2.
The invention also provides application of the fusion protein or the recombinant strain in casein decomposition.
The invention also provides application of the fusion protein or the recombinant strain in the fields of feed, brewing or food.
Advantageous effects
(1) The recombinant pichia pastoris GS115/pPIC 9K-en-alpha SP-acidoteta expression enzyme activity reaches 5395U/mL, and the enzyme activity is improved by 109% compared with that of a control strain containing the original alpha-signal peptide;
(2) the recombinant acid protease provided by the invention has the most suitable pH of 2.0, and can maintain the enzyme activity of more than 60% in the pH range of 1-5; the optimal temperature of the protease is 50 ℃, the residual enzyme activity is more than 80 percent after 30min of treatment at 20-40 ℃, and the protease has better stability. The invention realizes the production of protease with excellent property by using genetic engineering means, and applies the protease to industries such as feed, food, medicine and the like.
Drawings
FIG. 1 recombinant expression plasmid map;
FIG. 2 shows the optimum pH of the fungal-derived acid protease;
FIG. 3 shows the pH stability of fungal-derived acid protease;
FIG. 4 shows the optimum reaction temperature for fungal-derived acid protease;
FIG. 5 shows the thermostability of fungal-derived acid protease.
Detailed Description
(1) Culture medium:
seed medium YPD: tryptone 20g/L, yeast powder 10g/L, glucose 20 g/L.
Induction medium YP: tryptone 20g/L, yeast powder 10g/L, every 12h adding 1% (v/v) methanol.
(2) Detection of acid protease activity
And (3) carrying out activity analysis on the acidic protease by adopting a forskolin phenol reagent color development method. The specific method comprises the following steps: under the conditions of pH 3.0 and 55 ℃, 1mL of reaction system comprises 500 mu L of appropriately diluted enzyme solution and 500 mu L of substrate, the reaction is carried out for 10min, and 1mL of trichloroacetic acid (0.4mol/L) is added to stop the reaction; the reaction system was centrifuged at 12000rpm for 3min, 500. mu.L of the supernatant was aspirated, 2.5mL of sodium carbonate (0.4mol/L) was added, 500. mu.L of Folin's phenol reagent was added, and after development at 40 ℃ for 20min and cooling, the OD value was measured at 680 nm.
Protease activity unit definition: under certain conditions, the amount of enzyme required to decompose the substrate casein to 1. mu.g tyrosine per minute per ml reaction system was 1 activity unit (U).
Example 1 construction of recombinant Pichia pastoris
(1) Construction of recombinant plasmid pPIC 9K-en-alpha SP-acid
An enhanced alpha-signal peptide (en-alpha SP) with a nucleotide sequence shown as SEQ ID No.4 is connected to the N end of the acid protease with a nucleotide sequence shown as SEQ ID No.2, and is artificially synthesized, Bam HI and Not I enzyme cutting sites are respectively added at the head and the tail of the enhanced alpha-signal peptide, and the sequence connected with the enzyme cutting sites is integrated on a cloning vector pUC57 to form a plasmid pUC57-en alpha-SP-a-acid protein. The plasmid pUC57-en alpha-SP-acidiprotea is subjected to double enzyme digestion by Bam HI and Not I to obtain a 1428bp sequence containing an enhanced alpha-signal peptide and acid protease and is recovered, the vector pPIC9K is subjected to double enzyme digestion by Bam HI and Not I to obtain a 8998bp vector sequence and is recovered, the sequence containing the enhanced alpha-signal peptide and acid protease and the vector sequence are connected by DNA ligase to transform escherichia coli and coat a G418 resistant plate, after overnight culture, a single colony is picked up and used for amplifying thalli by an LB liquid culture medium, the plasmid is extracted and is sent to a company for sequencing verification, and the recombinant expression plasmid with correct sequencing is pPIC9K-en alpha SP-acidiprotea. The plasmid map is shown in FIG. 1.
(2) Construction of recombinant Pichia pastoris GS115/pPIC 9K-en-alpha SP-acidotea
Linearizing the recombinant plasmid pPIC 9K-en-alpha SP-acidprotea in the step (1) by using Sac I, electrically transforming a linearized product into pichia pastoris competence, and coating the pichia pastoris competence on a YPD solid culture medium containing G418 with a certain concentration for about 24-48 h at 28-30 ℃. And then respectively selecting full colonies with better morphology and transferring the colonies to a YPD liquid culture medium for re-screening. The method comprises the following specific steps:
1) pichia pastoris GS115 competence was prepared for transformation: sucking 30 mu L of P.pastoris GS115 wild strain into 10mL YPD liquid culture medium, and carrying out shake-flask culture at 30 ℃ and 200rpm for 24h to obtain activated P.pastoris GS 115; taking 100 mu L of activated P.pastoris GS115 to 100mL YPD culture medium, shaking and culturing at 30 ℃ and 200rpm until the bacterial concentration OD600 is 1.3-1.5, centrifuging all bacterial liquid at 4 ℃ and 5000rpm for 5min, discarding supernatant, adding 10mL Solution I to resuspend the thallus, and culturing in a water bath shaking table at 30 ℃ and 50rpm for 45 min; adding sterile water precooled by a refrigerator at 4 ℃ into the cultured thalli to a final volume of 30mL, resuspending the thalli, centrifuging at 5000rpm at 4 ℃ for 5min, and discarding the supernatant; resuspending the cells in 25mL of 4 ℃ pre-cooled sterile water, centrifuging at 4 ℃ and 5000rpm for 5min, removing the supernatant, and repeating the operation once; resuspending the thallus with 25mL of 1mol/L sorbitol precooled at 4 ℃, centrifuging at 5000rpm at 4 ℃ for 5min, removing supernatant, and repeating the operation once; the cells were resuspended in 1mL, 1mol/L sorbitol and aliquoted into EP tubes, 80. mu.L each, for further experiments.
2) The plasmid pPIC 9K-en-alpha SP-acididiotea extracted in the step (1) is linearized by endonuclease Sac I, the linearized plasmid (5-10ug) is added into 80uL of yeast competent cells obtained in the step 1), and the cells are transferred into ice-precooled 0.2cm electric rotating cups and placed on ice for 5-10 min. 2000V; performing electric shock once within 5ms, immediately adding 0.5-2mL of 1mol/L ice-precooled sorbitol, uniformly mixing, transferring the mixture into a sterile centrifuge tube, standing for 1-2 h at 30 ℃, adding 0.5-1.5 mL of YPD medium, and culturing for 1-2 h at 30 ℃ and 20-100 rpm to obtain a mixed solution; centrifuging the mixed solution at 3000-6000 rpm for 1-5 min, removing part of supernatant, remaining 100. mu.L of resuspended thallus, coating YPD resistant plates containing a certain concentration of G418, and culturing at 30 ℃ for 1-4 days to pick out the monoclonal. And then, respectively selecting full colonies with better morphology, transferring the colonies to a YPD solid culture medium, and carrying out secondary screening.
The construction method of the recombinant pichia pastoris GS115/pPIC9K-acidprotea containing the original alpha-signal peptide is the same as that of the recombinant pichia pastoris GS115/pPIC 9K-en-alpha SP-acidprotea, and only the enhanced alpha-signal peptide with the nucleotide sequence shown as SEQ ID NO.4 is replaced by the original alpha-signal peptide with the nucleotide sequence shown as SEQ ID NO. 5.
Example 2 production of acid protease by recombinant Pichia pastoris shake flask fermentation
From the plate containing recombinant Pichia pastoris GS115/pPIC9K-en- α SP-acidprotea obtained in example 1, 10 single colonies were picked and inoculated into 25mL of liquid medium YPD, cultured at 30 ℃ and 220rpm for 24 hours, at 6000rpm at room temperature, centrifuged for 5min, the cells were collected, the supernatant was discarded, the cells were resuspended in 30mL of liquid medium YP, induction expression was performed at 28 ℃ and 220rpm, methanol was added every 24 hours to a final concentration of 1% to continue induction, and the flask was subjected to flask shaking induction for 72 hours to obtain a fermentation broth.
The recombinant strain P.pastoris GS115/pPIC9K-acidprotea containing the original α -signal peptide obtained in example 1 was used as a control strain, and induction culture was performed simultaneously.
And finally, when the bottle is shaken, 2580U/mL of enzyme activity of the control strain using the original alpha-signal peptide is adopted, 5395U/mL of the average value of the enzyme activity of the strain using the enhanced alpha-signal peptide is adopted, and the expression level is improved by 109%.
EXAMPLE 3 enzymatic Properties of recombinant acid proteases
(1) Purification of acid proteases
Centrifuging the fermentation liquid obtained in example 2 at 4 deg.C and 8000r/min for 10min, collecting the supernatant to obtain crude enzyme solution, and adding 20mmol/L NaH2PO4-Na2HPO4(p H6.5.5) buffer solution, 10kDa ultrafiltration membrane package were used to dialyze the crude enzyme solution. Collecting the crude enzyme solution after dialysis, centrifuging at 12000r/min at 4 deg.C for 30min, and collecting supernatant.
The protein was purified using a HitrapTM Q FP (5mL) anion exchange chromatography column. The protein of the crude enzyme solution is separated and purified by using an AKTA protein purifier, and the column purification conditions are as follows: the anion column was equilibrated with 10 column volumes of buffer A (20mmol/L NaH2PO4-Na2HPO4 buffer, pH 6.5) and injected at a flow rate of 1 mL/min; after sample injection is finished, flushing the column by using buffer solution A with 5 column volumes; and linear elution was performed with 0-100% buffer B (20mmol/L NaH2PO4-Na2HPO4+1mol/L NaCl buffer, pH 6.5) at a flow rate of 1 mL/min. And collecting samples in the elution peak, determining a collecting pipe where the target sample is located through enzyme activity determination, and obtaining the electrophoretically pure target protein.
(2) Optimum pH and pH stability of acid protease
Optimum pH: recombinant acid proteases containing the enhanced alpha-signal peptide were enzymatically reacted at a temperature of 50 ℃ at various pH's to determine their optimum pH. The buffer solution is glycine-hydrochloric acid buffer solution with pH value of 1.0-3.0, citric acid-disodium hydrogen phosphate buffer solution with pH value of 3.0-80, and Tris-HC1 buffer solution with pH value of 8.0-10.0. The optimum pH of the enzyme was determined with the highest enzyme activity detected in this example being 100%, as shown in FIG. 2, the optimum pH of the acid protease was 2.0.
pH stability: the recombinant acid protease containing the enhanced alpha-signal peptide is placed in buffers with different pH values and treated for 60min at 50 ℃, the enzyme activity is measured, the untreated enzyme activity is 100 percent, and the pH stability of the enzyme is researched. As shown in FIG. 3, the acid protease can maintain more than 60% of enzyme activity between pH 1.0-5.0, which indicates that the enzyme has excellent pH stability.
(3) Optimum temperature and thermal stability of acid protease reaction
Optimum temperature: under the condition of pH 2.0, the enzyme activity of the recombinant acid protease containing the enhanced alpha-signal peptide is measured at 20-90 ℃, and the optimum temperature of the recombinant acid protease is determined by taking the highest enzyme activity detected in the implementation process as 100%. As shown in FIG. 4, the recombinant acid protease containing the enhanced alpha-signal peptide of the present invention has an optimum reaction temperature of 50 ℃ and an enzyme activity of 60% or more at 40 ℃.
Thermal stability: under the condition of pH 2.0, the recombinant acid protease containing the enhanced alpha-signal peptide is treated for 30min at the temperature of 20-90 ℃, the enzyme activity is measured, and the thermal stability of the enzyme is researched by taking the untreated enzyme activity as 100%. As shown in figure 5, the recombinant acid protease containing the enhanced alpha-signal peptide can still keep more than 90% of enzyme activity after being treated at 30 ℃ for 30min, and the residual enzyme activity is more than 80% after being treated at 40 ℃ for 30 min; after the enzyme is treated at 50 ℃ for 30min, the residual enzyme activity is more than 40 percent, even though the enzyme has better stability at 20-40 ℃.
EXAMPLE 4 use of recombinant acid proteases
Freeze-drying the acid protease obtained in the step (1) of the embodiment 3 to prepare enzyme powder; is prepared from grape 800 parts, purified water 800 parts, white granulated sugar 200 parts, Saccharomyces cerevisiae 0.06 part, pectase 0.01 part, cellulase 0.01 part, acid protease 0.04 part, CaCl20.01 part of the fruit wine is prepared by fermentation.
Although the present invention has been described with reference to the preferred embodiments, it should be understood that various changes and modifications can be made therein by those skilled in the art without departing from the spirit and scope of the invention as defined in the appended claims.
SEQUENCE LISTING
<110> university of south of the Yangtze river
<120> method for efficiently expressing acid protease and application thereof
<130> BAA210489A
<160> 5
<170> PatentIn version 3.3
<210> 1
<211> 374
<212> PRT
<213> Artificial sequence
<400> 1
Ala Pro Ala Pro Thr Arg Lys Gly Phe Thr Ile Asn Gln Ile Ala Arg
1 5 10 15
Pro Ala Asn Lys Thr Arg Thr Ile Asn Leu Pro Gly Met Tyr Ala Arg
20 25 30
Ser Leu Ala Lys Phe Gly Gly Thr Val Pro Gln Ser Val Lys Glu Ala
35 40 45
Ala Ser Lys Gly Ser Ala Val Thr Thr Pro Gln Asn Asn Asp Glu Glu
50 55 60
Tyr Leu Thr Pro Val Thr Val Gly Lys Ser Thr Leu His Leu Asp Phe
65 70 75 80
Asp Thr Gly Ser Ala Asp Leu Trp Val Phe Ser Asp Glu Leu Pro Ser
85 90 95
Ser Glu Arg Thr Gly His Asp Val Tyr Thr Pro Ser Ser Ser Ala Thr
100 105 110
Lys Leu Ser Gly Tyr Thr Trp Asp Ile Ser Tyr Gly Asp Gly Ser Ser
115 120 125
Ala Ser Gly Asp Val Tyr Arg Asp Thr Val Thr Val Gly Gly Val Thr
130 135 140
Thr Asn Lys Gln Ala Val Glu Ala Ala Ser Lys Ile Ser Ser Glu Phe
145 150 155 160
Val Gln Asn Thr Ala Asn Asp Gly Leu Leu Gly Leu Ala Phe Ser Ser
165 170 175
Ile Asn Thr Val Gln Pro Lys Ala Gln Thr Thr Phe Phe Asp Thr Val
180 185 190
Lys Ser Gln Leu Asp Ser Pro Leu Phe Ala Val Gln Leu Lys His Asp
195 200 205
Ala Pro Gly Val Tyr Asp Phe Gly Tyr Ile Asp Asp Ser Lys Tyr Thr
210 215 220
Gly Ser Ile Thr Tyr Thr Asp Ala Asp Ser Ser Gln Gly Tyr Trp Gly
225 230 235 240
Phe Asn Pro Asp Gly Tyr Ser Ile Gly Asp Gly Ser Ser Ser Ser Ser
245 250 255
Gly Phe Ser Ala Ile Ala Asp Thr Gly Thr Thr Leu Ile Leu Leu Asp
260 265 270
Asp Glu Ile Val Ser Ala Tyr Tyr Glu Gln Val Ser Gly Ala Gln Glu
275 280 285
Ser Glu Glu Ala Gly Gly Tyr Val Phe Ser Cys Ser Thr Asn Pro Pro
290 295 300
Asp Phe Thr Val Val Ile Gly Asp Tyr Lys Ala Val Val Pro Gly Lys
305 310 315 320
Tyr Ile Asn Tyr Ala Pro Ile Ser Thr Gly Ser Ser Thr Cys Phe Gly
325 330 335
Gly Ile Gln Ser Asn Ser Gly Leu Gly Leu Ser Ile Leu Gly Asp Val
340 345 350
Phe Leu Lys Ser Gln Tyr Val Val Phe Asn Ser Glu Gly Pro Lys Leu
355 360 365
Gly Phe Ala Ala Gln Ala
370
<210> 2
<211> 1122
<212> DNA
<213> Artificial sequence
<400> 2
gccccagctc caactagaaa gggttttact attaaccaaa ttgctagacc agctaacaag 60
actagaacta ttaacttgcc aggtatgtac gctagatcct tggctaagtt tggtggtaca 120
gttccacaat ctgttaaaga agctgctagt aagggttctg ccgttactac tccacaaaac 180
aatgatgaag aatacttgac tccagttact gttggtaaat ctactttgca tttggatttt 240
gatactggtt ctgctgattt gtgggttttc tctgatgaat tgccatcttc tgaaagaact 300
ggtcatgatg tttatactcc atcttcttct gctactaaat tgtctggtta tacctgggat 360
atttcttacg gtgacggttc ttctgctagt ggtgacgttt acagagatac tgttactgtt 420
ggtggagtta caactaacaa gcaagccgtt gaagctgctt ctaaaatttc ttcagaattt 480
gttcaaaata ctgctaacga tggattgttg ggtttggcat tttcttctat taacactgtt 540
caaccaaagg ctcaaactac tttctttgat accgttaagt ctcaacttga ttctccattg 600
tttgctgttc aattgaaaca cgatgctcca ggtgtttacg atttcggtta tattgatgat 660
tctaaataca ctggttccat cacttatact gatgctgact ctagtcaagg ttattggggt 720
tttaacccag atggttactc cattggagat ggatcttcct cctcttccgg tttttctgct 780
attgctgata ctggtacaac tctgattttg ttggatgatg aaattgtttc tgcttactac 840
gagcaagttt caggagccca agaatctgag gaagctggtg gttatgtttt ctcttgttct 900
actaatccac cagattttac tgttgtcatt ggagattata aggctgttgt tccaggtaaa 960
tacattaact acgctccaat ttccactggt tcttctactt gttttggtgg tattcaatct 1020
aactccggtt tgggtttgtc tattttgggt gacgttttct tgaaatctca atatgttgtt 1080
tttaactctg aaggtcctaa gttgggtttt gctgctcaag ct 1122
<210> 3
<211> 102
<212> PRT
<213> Artificial sequence
<400> 3
Met Ala Ile Pro Arg Phe Pro Ser Ile Phe Thr Ala Val Leu Phe Ala
1 5 10 15
Ala Ser Ser Ala Leu Ala Ala Pro Val Asn Thr Thr Thr Glu Asp Glu
20 25 30
Thr Ala Gln Ile Pro Ala Glu Ala Val Ile Gly Tyr Ser Asp Leu Glu
35 40 45
Gly Asp Phe Asp Val Ala Val Leu Pro Phe Ser Asn Ser Thr Asn Asn
50 55 60
Gly Leu Leu Glu Glu Ala Glu Ala Glu Ala Glu Pro Lys Phe Ile Asn
65 70 75 80
Thr Thr Ile Ala Ser Ile Ala Ala Lys Glu Glu Gly Val Ser Leu Glu
85 90 95
Lys Arg Glu Ala Glu Ala
100
<210> 4
<211> 307
<212> DNA
<213> Artificial sequence
<400> 4
atggctatcc caagattccc atctattttc accgctgttc tgttcgctgc ttcttctgct 60
ttggctgctc cagttaatac tactactgaa gatgagactg cccaaattcc agctgaagct 120
gttattggtt actctgattt ggagggtgat ttcgatgttg ctgttttgcc attttccaac 180
tctactaaca acggtttgct ggaagaagct gaagctgaag ccgaaccaaa atttattaac 240
accaccatcg cctctatcgc tgctaaagaa gaaggtgttt ctttggaaaa gagagaggct 300
gaagcta 307
<210> 5
<211> 89
<212> PRT
<213> Artificial sequence
<400> 5
Met Arg Phe Pro Ser Ile Phe Thr Ala Val Leu Phe Ala Ala Ser Ser
1 5 10 15
Ala Leu Ala Ala Pro Val Asn Thr Thr Thr Glu Asp Glu Thr Ala Gln
20 25 30
Ile Pro Ala Glu Ala Val Ile Gly Tyr Ser Asp Leu Glu Gly Asp Phe
35 40 45
Asp Val Ala Val Leu Pro Phe Ser Asn Ser Thr Asn Asn Gly Leu Leu
50 55 60
Phe Ile Asn Thr Thr Ile Ala Ser Ile Ala Ala Lys Glu Glu Gly Val
65 70 75 80
Ser Leu Glu Lys Arg Glu Ala Glu Ala
85

Claims (10)

1. A fusion protein is characterized in that the fusion protein is an acid protease with an enhanced alpha-signal peptide connected to the N end; the nucleotide sequence of the acid protease is shown as SEQ ID NO. 2; the nucleotide sequence of the enhanced alpha-signal peptide is shown in SEQ ID NO. 4.
2. A vector expressing the fusion protein of claim 1.
3. A recombinant strain comprising the fusion protein of claim 1 or the vector of claim 2.
4. The recombinant strain of claim 3, wherein the recombinant strain is host Pichia pastoris and vector pPIC 9K.
5. The recombinant strain of claim 4, wherein the Pichia pastoris comprises Pichia pastoris GS115, KM71, and X33.
6. A method for constructing the recombinant strain of claim 3, which comprises the following specific steps: (1) connecting and inserting the acid protease and the enhanced alpha-signal peptide into an expression vector pUC57 to obtain a recombinant vector pUC57-en alpha-SP-acidiprotea; (2) using the recombinant vector pUC57-en alpha-SP-acidiprotea in the step (1) as a template, amplifying a target fragment containing acid protease and enhanced alpha-signal peptide, and inserting the target fragment into an expression vector pPIC9K to obtain a recombinant vector pPIC 9K-en-alpha SP-acidiprotea; (3) and (3) linearizing the recombinant vector in the step (2) and transforming the recombinant vector into pichia pastoris to obtain a recombinant strain.
7. A method for increasing the expression level of acid protease, which comprises: connecting the gene sequence of the enhanced alpha-signal peptide to the N end of the acid protease gene sequence; the nucleotide sequence of the enhanced alpha-signal peptide is shown as SEQ ID NO. 4; the acid protease comprises acid protease of animal or fungus origin.
8. The method of claim 7, wherein the acid protease has the sequence shown in SEQ ID No. 2.
9. Use of the fusion protein of claim 1 or the recombinant strain of claim 3 for casein degradation.
10. Use of the fusion protein according to claim 1 or the recombinant strain according to claim 3 in the field of feed, brewing or food.
CN202110436308.0A 2021-04-22 2021-04-22 Method for efficiently expressing acid protease and application thereof Active CN112920280B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110436308.0A CN112920280B (en) 2021-04-22 2021-04-22 Method for efficiently expressing acid protease and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110436308.0A CN112920280B (en) 2021-04-22 2021-04-22 Method for efficiently expressing acid protease and application thereof

Publications (2)

Publication Number Publication Date
CN112920280A true CN112920280A (en) 2021-06-08
CN112920280B CN112920280B (en) 2022-07-05

Family

ID=76174698

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110436308.0A Active CN112920280B (en) 2021-04-22 2021-04-22 Method for efficiently expressing acid protease and application thereof

Country Status (1)

Country Link
CN (1) CN112920280B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113481115A (en) * 2021-07-06 2021-10-08 江南大学 Recombinant pichia pastoris for expressing human alpha-lactalbumin as well as construction method and application thereof
CN114908109A (en) * 2022-06-14 2022-08-16 中农华威生物制药(湖北)有限公司 Construction and batch fermentation process suitable for acidic protease expression strain in feed

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0792367A1 (en) * 1993-07-08 1997-09-03 Novo Nordisk A/S A dna construct encoding the yap3 signal peptide
CN101831414A (en) * 2010-05-25 2010-09-15 江南大学 Process for extracellularly producing recombinant alpha-cyclodextrin glucosyltransferase
CN103483432A (en) * 2013-09-16 2014-01-01 广州吉格生物科技有限公司 Signal peptide optimizing efficient secretory expression of Savinase and application thereof
CN107586789A (en) * 2017-10-11 2018-01-16 南京百斯杰生物工程有限公司 High yield acid protease aspergillus niger recombinant strains and its construction method and application

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0792367A1 (en) * 1993-07-08 1997-09-03 Novo Nordisk A/S A dna construct encoding the yap3 signal peptide
CN101831414A (en) * 2010-05-25 2010-09-15 江南大学 Process for extracellularly producing recombinant alpha-cyclodextrin glucosyltransferase
CN103483432A (en) * 2013-09-16 2014-01-01 广州吉格生物科技有限公司 Signal peptide optimizing efficient secretory expression of Savinase and application thereof
CN107586789A (en) * 2017-10-11 2018-01-16 南京百斯杰生物工程有限公司 High yield acid protease aspergillus niger recombinant strains and its construction method and application

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
LATIFFI A A等: "Secretory expression of thermostable alkaline protease from Bacillus stearothermophilus FI by using native signal peptide and α-factor secretion signal in Pichia pastoris", 《GENES & GENETIC SYSTEMS》 *
NCBI: "aspergillopepsin A-like aspartic endopeptidase [Aspergillus niger CBS 513.88]", 《GENBANK DATABASE》 *
NCBI: "mating factor alpha preproprotein, partial [synthetic construct]", 《GENBANK DATABASE》 *
NCBI: "Phaeoacremonium minimum UCRPA7 putative aspartyl protease protein partial mRNA", 《GENBANK DATABASE》 *
NCBI: "Synthetic construct OB1 laccase gene, complete cds", 《GENBANK DATABASE》 *
杨歧生: "《分子生物学》", 31 January 1998, 浙江大学出版社 *
王光强等: "枯草芽孢杆菌中Sec分泌途径底物特性及非经典分泌途径的研究", 《中国优秀博硕士学位论文全文数据库(博士) 工程科技Ⅰ辑》 *
禹邦超: "《酶工程》", 31 January 2014, 华中师范大学出版社 *
程婧等: "复合与合成培养基对大肠杆菌胞外生产α-环糊精葡萄糖基转移酶的影响", 《中国生物工程杂志》 *
马纳纳等: "一种新颖的毕赤酵母酸性蛋白酶基因的克隆和异源表达以及酶学性质研究", 《广东农业科学》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113481115A (en) * 2021-07-06 2021-10-08 江南大学 Recombinant pichia pastoris for expressing human alpha-lactalbumin as well as construction method and application thereof
CN114908109A (en) * 2022-06-14 2022-08-16 中农华威生物制药(湖北)有限公司 Construction and batch fermentation process suitable for acidic protease expression strain in feed
CN114908109B (en) * 2022-06-14 2023-11-10 中农华威生物制药(湖北)有限公司 Construction of acid protease expression strain suitable for feed and batch fermentation process

Also Published As

Publication number Publication date
CN112920280B (en) 2022-07-05

Similar Documents

Publication Publication Date Title
CN100526458C (en) Alpha-galactosidase gene, its coding protein, production and use
CN112920280B (en) Method for efficiently expressing acid protease and application thereof
CN107384900B (en) The acid protease 6749 and its gene of a kind of originated from fungus and application
RU2642290C2 (en) Application of endogenic dnaase activity to reduce dna content
CN109371004B (en) Acid protease Bs2688 mutant K203E with improved thermal stability and gene and application thereof
CN107384899B (en) Fungus-derived acidic protease g412 and gene and application thereof
CN111893126A (en) Alkaline protease gene, alkaline protease, preparation method and application thereof
CN107760659A (en) It is a kind of to recombinate proline aminopeptidase fermentation high yield and prepare the method for taking off bitter rice peptide
KR102152138B1 (en) An activity-improved xylanase mutant and a method for producing the same
EP3604542A1 (en) Expression of phytase in aspergillus niger
CN111996205A (en) Chitinase gene, chitinase and preparation method and application thereof
CN111607582A (en) Lysozyme with enzyme activity improving function
CN107988190B (en) Acid protease and coding gene and application thereof
CN101457208B (en) Anti-protease acidic alpha-galactosidase Aga-F75 and gene and application thereof
CN114736881B (en) Glucose oxidase GoxM10 mutant A4D with improved acid stability and derivative mutant and application thereof
CN114736880B (en) Mutant D497N of glucose oxidase GoxM10 with improved acid stability as well as derivative mutant and application thereof
CN109810967B (en) Acid protease Bs2688 mutant Y282L with improved thermal stability and gene and application thereof
CN1245507C (en) High temperaturebeta- glucosaccharase, coding gene and uses thereof
CN113832129B (en) Chitosanase mutant CsnBa1 and application thereof
CN114774396A (en) Keratinase mutant, compound preparation of keratinase mutant and bile acid and application of compound preparation in additive
CN101067117A (en) Process of producing heat resistant xylanase with genetically recombinant Pichia yeast
CN109161489B (en) Aspergillus niger strain with high yield of acid protease
CN109251867B (en) High-yield strain of acid protease and application thereof
CN105838693B (en) A kind of high temperature resistant acidic pectase PAGL8 and its gene and application
CN112852654B (en) PAS _ chr1-3_0141 gene knockout pichia pastoris gene engineering strain and construction method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant